« Previous
Next »
The Journal of Urology
Volume 177, Issue 6
, Pages
2136-2140
, June 2007
Low Dose Metronomic Oral Cyclophosphamide for Hormone Resistant Prostate Cancer: A Phase II Study
To access this article, please choose from the options below
Study received approval from St. Georges Hospital Local Research Ethics Committee.
PII: S0022-5347(07)00281-9
doi: 10.1016/j.juro.2007.01.143
© 2007 American Urological Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Urology
Volume 177, Issue 6
, Pages
2136-2140
, June 2007

